Showing results (181-190 of 222) with videos related to

Sort By:
Pageof 23
Cancer Research|August 5, 2020
Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian CarcinomaLudwig Geistlinger, Sehyun Oh, Marcel Ramos, et al.
Gynecologic Oncology|October 4, 2017
Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group studyEric J Devor, Jeffrey Miecznikowski, Brandon M Schickling, et al.
Scientific Reports|January 27, 2023
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinomaSho Sato, Michael Gillette, Pamela R de Santiago, et al.
Gynecologic Oncology|March 5, 2019
GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group studyRebecca A Brooks, David S Tritchler, Kathleen M Darcy, et al.
JAMA Oncology|January 1, 2016
Inherited Mutations in Women With Ovarian CarcinomaBarbara M Norquist, Maria I Harrell, Mark F Brady, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2011
IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancerMichael S Anglesio, Joshy George, Hagen Kulbe, et al.
Cancer Cell|December 8, 2009
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2Samuel C Mok, Tomas Bonome, Vinod Vathipadiekal, et al.
Gynecologic Oncology|December 15, 2021
Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 studyElizabeth M Swisher, Carol Aghajanian, David M O'Malley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2017
Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group StudyBarbara M Norquist, Mark F Brady, Maria I Harrell, et al.
Plos One|July 15, 2011
Identification of novel therapeutic targets in microdissected clear cell ovarian cancersMichael P Stany, Vinod Vathipadiekal, Laurent Ozbun, et al.
Pageof 23